Evidence map›Paper›PMID 39670749›Full record

ArticleAntimicrobial agents and chemotherapy2025

Kirsten Salado-Rasmussen, Christina Nørgaard, Thomas Roland Pedersen, Susanne Paukner, Jørgen Skov Jensen

Abstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Treatment Approaches for RefractoryOpen forum infectious diseases · 2026
    Article
  6. Article
  7. Mycoplasma Genitalium - Where are we at?Current HIV/AIDS reports · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Kirsten Salado-RasmussenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-0614-8247
Christina NørgaardDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Thomas Roland PedersenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.
Susanne PauknerNabriva Therapeutics GmbH, Vienna, Austria.
Jørgen Skov JensenDepartment of Bacteria, Parasites and Fungi, Statens Serum Institut, Copenhagen, Denmark.ORCID 0000-0002-7464-7435

Funding

Nabriva Therapeutics (Nabriva)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Anti-Bacterial AgentsDoxycyclineMycoplasma genitaliumThioglycolatesDiterpenesDrug SynergismFemaleHumansMicrobial Sensitivity TestsMycoplasma InfectionsPolycyclic CompoundsAnti-Bacterial AgentsDiterpenesDoxycyclinelefamulinPolycyclic CompoundsThioglycolatesantibiotic resistancelefamulinMycoplasma genitaliumpleuromutilin

Identifiers

PMID39670749
PMCPMC11784443

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.